Menarini Asia-Pacific
Menarini is the world’s largest Italian biopharmaceutical company with a heritage of over 128 years, and more than 16,000 employees in over 100 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people in the region.
See below for the Latest Menarini Asia-Pacific News, Analysis, Profit Results, Share Price Information, and Commentary.
How Menarini Asia Pacific achieves organisational excellence, harnesses agile go-to market approaches
How Menarini Asia Pacific achieves organisational excellence, harnesses agile go-to market approaches
CEO Maurizio Luongo highlights the expansion of the company’s omni-channel distribution strategy beyond traditional pharmaceuticals channels.
Menarini Asia-Pacific bags two awards at the SBR Management Excellence Awards 2022
It was recognised for having a robust team and an outstanding leader that guided the company to success.
Read Here
Advertise
Sign Up
Commentary
What Singapore’s app store rules reveal about the future of online trust
Faster hiring alone will not fix construction’s productivity problem
Beyond policy: How Singapore's service sector can win at the frontline
Solving the production problem behind Singapore’s ‘pilot purgatory’
Transformation without disruption: Your Existing ERP is an accelerant to business innovation
From Singapore to Southeast Asia: Thriving in innovation by knowing when to pause
Section 13O, MAS, and the digital footprint of Singapore Family Offices
Could Singapore lead the world's next management revolution?
RIE2030’s real test: Turning innovation into impact
What Singapore logistics operators often overlook when electrifying fleets